TSO3 and GETINGE Infection Control Sign Exclusive Global Distribution Agreement

Québec City, Québec – November 25, 2015 – TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, has granted Getinge Infection Control AB, a global leader in infection control solutions, exclusive global distributor rights to its FDA-cleared, STERIZONE® VP4 Sterilizer for US$7.5 million, plus performance minimums.

Read more